Search Results 91-100 of 1747 for 搜索引擎yandex咨询邮箱:lgooxc@hotmail.com
Mayo Clinic researcher Lioudmila V. Karnatovskaia, M.D., strives to improve outcomes for people surviving critical illnesses.
Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...
Search the more than 400 medical, surgical, health sciences, and biomedical research training programs at Mayo Clinic College of Medicine and Science.
Mayo Clinic researcher Jason S. Eldrige, M.D., focuses on clinical treatment for complex spine pain, including minimally invasive procedures and ...
About this study. Recent reports have identified a specific oncogenic mutation L265P of the MYD88 gene in approximately 30% of the patients with the ...
About this study. The purpose of this study is to evaluate the reduction in the peritoneal recurrence at 18 months for patients receiving p-HIPEC.
Mayo Clinic's Department of Laboratory Medicine and Pathology in Rochester, Minnesota, is one of the largest clinical laboratories in the world.
I currently work in outreach Radiation Oncology; participating in NCCTG sponsored trials here at the Albert Lea Cancer Center. PROFESSIONAL DETAILS. Primary ...
Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.